Frequency of Sudden Cardiac Death Among Acute Myocardial Infarction Survivors With Optimized Medical and Revascularization Therapy

The epidemiologic pattern of sudden cardiac death (SCD) may have changed in the modern treatment era of patients after an acute myocardial infarction (AMI). We evaluated the effect of optimized medical and revascularization therapy on the incidence of SCD after an AMI. A total of 2,130 consecutive p...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2006-02, Vol.97 (4), p.480-484
Main Authors: Mäkikallio, Timo H., Barthel, Petra, Schneider, Raphael, Bauer, Axel, Tapanainen, Jari M., Tulppo, Mikko P., Perkiömäki, Juha S., Schmidt, Georg, Huikuri, Heikki V.
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Aspirin - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Coronary heart disease
Death, Sudden, Cardiac - etiology
Epidemiology
Fatalities
Female
Follow-Up Studies
Heart
Heart attacks
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Male
Medical sciences
Medical treatment
Middle Aged
Myocardial Infarction - mortality
Myocardial Infarction - therapy
Myocardial Revascularization
Myocarditis. Cardiomyopathies
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The epidemiologic pattern of sudden cardiac death (SCD) may have changed in the modern treatment era of patients after an acute myocardial infarction (AMI). We evaluated the effect of optimized medical and revascularization therapy on the incidence of SCD after an AMI. A total of 2,130 consecutive patients (mean age 59 ± 10 years) with an AMI from 2 European centers (Germany and Finland) was included in the study. In this population, 1,004 patients (47%) were treated with an optimized medical and revascularization strategy (defined as treatment with revascularization, β blockers, aspirin, statins, and angiotensin-converting enzyme inhibitors). Nonoptimized treatment, defined as a lack of any optimized treatment, was received by 1,126 patients (53%). During the mean follow-up of 2.9 ± 1.3 years, the incidence of SCD was very low among patients who received optimized treatment (1.2%, annual incidence 0.4%) compared with those who did not (3.6%, annual incidence 1.4%, p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2005.09.077